查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1497590

製药业人工智慧市场：按产品、技术、应用和最终用户划分 - 2024-2030 年全球预测

Artificial Intelligence in Pharmaceutical Market by Offering (Hardware, Services, Software), Technology (Computer Vision, Context-Aware Computing, Machine Learning), Applications, End-users - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年人工智慧在製药领域的市场规模为162.1亿美元，预计2024年将达到207.6亿美元，2030年将达到973.5亿美元，复合年增长率为29.18%。

製药市场中的人工智慧（AI）是指将先进的机器学习演算法、自然语言处理和资料分析技术整合到全球製药业的药物发现、开发和製造过程中。为了改善治疗效果而对个人化医疗的需求不断增长，以及基因组学和高通量技术的进步产生了大量复杂的资料，需要先进的分析技术。然而，用于训练机器学习模型的精选资料集的可用性有限，阻碍了人工智慧在医学中的采用。然而，将巨量资料分析与人工智慧结合还可以提高我们对各种疾病分子机制的理解，并确定可能成为未来药物标靶的新型生物标记。

主要市场统计
基准年[2023] 162.1亿美元
预测年份 [2024] 207.6亿美元
预测年份 [2030] 973.5亿美元
复合年增长率（%） 29.18%

区域洞察

在美国，由于先进技术的早期采用和政府的支援政策，医药人工智慧市场的环境正在改善。美国拥有多家领先的人工智慧新兴企业，它们利用人工智慧进行药物发现、分子建模、临床试验优化和个人化医疗。在美国，大型製药企业正在与人工智慧主导的新兴企业合作，并大力投资研究，以加速药物发现和开发。在欧洲地区，法国、德国、英国等国纷纷推出国家战略，推动人工智慧在医药等各产业的应用。儘管与其他地区相比进展缓慢，但中东国家正在透过人工智慧投资取得进展。非洲的潜力在于透过其不断发展的製药生态系统来应对其独特的医疗保健挑战。在亚太地区，以中国、日本和印度为首的利用人工智慧的药物方面取得了显着的进展。此外，公共和私人对製药基础设施的投资不断增加，为引入人工智慧创造了积极的环境。

FPNV定位矩阵

FPNV 定位矩阵对于评估製药市场人工智慧供应商的市场定位至关重要。此矩阵提供了对供应商的全面评估，并检验了与商务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果，供应商被分为代表其成功程度的四个像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可对製药市场人工智慧供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献，您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他重要指标。此外，该分析也为该领域的竞争性质提供了宝贵的见解，包括累积研究期、片段化优势和合併特征等因素。有了这些详细信息，供应商可以做出更明智的决策并製定有效的策略，以在市场竞争中保持领先地位。

策略分析与建议

策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对人工智慧在製药市场中的当前地位进行全面评估，使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析，以确定核心优势和需要改进的领域。

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 对个人化医疗以改善治疗结果的需求不断增长
      • 利用人工智慧驱动的方法来增强现有的药物再利用策略
      • 需要加强生物医学和临床资料处理
    • 抑制因素
      • 开发和实施人工智慧解决方案需要大量初始投资
    • 机会
      • 介绍针对製药业的人工智慧为基础的创新解决方案
      • 大量投资人工智慧药物发现研究
    • 任务
      • 资料隐私和安全问题
  • 市场区隔分析
    • 我们提供什么：由于功能和能力的改进，基于人工智慧的软体的采用率有所提高
    • 技术：扩大机器学习技术在製药领域的应用
    • 应用：利用人工智慧解决方案简化临床试验流程
    • 最终用户：製药和生物技术公司大规模采用人工智慧技术进行药物发现和开发
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 製药领域的人工智慧市场：透过提供

  • 硬体
  • 服务
  • 软体

第七章 製药领域的人工智慧市场：依技术分类

  • 电脑视觉
  • 上下文感知计算
  • 机器学习
  • 自然语言处理
  • 查询方式

第八章 製药领域的人工智慧市场：依应用分类

  • 临床试验
  • 诊断支持与个人化治疗
  • 药物开发和发现
  • 製造业
  • 行销

第九章 製药业的人工智慧市场：依最终用户分类

  • 製药和生物技术公司
  • 调查机构

第十章 美洲製药领域的人工智慧市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区医药人工智慧市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章：欧洲、中东和非洲製药业的人工智慧市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 默克建立两个策略联盟以加强人工智慧驱动的药物发现
    • In Silico的第二阶段计划的启动凸显了生成式人工智慧的发展势头
    • Google Cloud 宣布推出利用 AI 安全加速药物发现和精准医疗的解决方案
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-A6768A62EE00

[189 Pages Report] The Artificial Intelligence in Pharmaceutical Market size was estimated at USD 16.21 billion in 2023 and expected to reach USD 20.76 billion in 2024, at a CAGR 29.18% to reach USD 97.35 billion by 2030.

Artificial intelligence (AI) in the pharmaceutical market refers to integrating advanced machine learning algorithms, natural language processing, and data analytics technologies into the drug discovery, development, and manufacturing processes of the global pharmaceutical industry. The growing demand for personalized medicine to improve treatment outcomes and advancements in genomics and high-throughput technologies generate large volumes of complex data requiring advanced analytical techniques. However, the limited availability of curated datasets for training machine learning models hinders the adoption of AI in pharmaceuticals. Nevertheless, integrating big data analytics with AI may also facilitate a better understanding of molecular mechanisms underlying various diseases or identify novel biomarkers that could be targets of future drugs; this further creates lucrative opportunities for the market.

KEY MARKET STATISTICS
Base Year [2023] USD 16.21 billion
Estimated Year [2024] USD 20.76 billion
Forecast Year [2030] USD 97.35 billion
CAGR (%) 29.18%

Regional Insights

America provides an improved landscape for the AI in pharmaceutical market with an early adoption of advanced technologies and supportive government policies. The United States is home to several leading AI startups leveraging AI for drug discovery, molecular modeling, clinical trials optimization, and personalized medicine. In the U.S., major pharmaceutical firms are partnering with AI-driven startups and investing heavily in research to expedite drug discovery and development. In the European region, countries such as France, Germany, and the United Kingdom have introduced national strategies propelling AI applications across industries, including pharmaceuticals. Although slower in comparison to other regions, Middle Eastern countries are advancing through investment in AI. Africa's potential lies in addressing unique healthcare challenges through its developing pharma ecosystem. The Asia Pacific region showcases significant growth in AI-driven pharmaceutical advancements with China, Japan, and India at the forefront. In addition, increasing public-private investments in pharmaceutical manufacturing infrastructure provides a positive landscape for AI deployments.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Artificial Intelligence in Pharmaceutical Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Growing demand for personalized medicine to improve treatment outcomes
      • Utilization of AI-driven approaches to enhance existing drug repurposing strategies
      • Need to enhance processing of biomedical and clinical data
    • Market Restraints
      • High initial investment for developing and implementing AI solutions
    • Market Opportunities
      • Introduction of innovative AI-based solutions for pharmaceutical industry
      • Significant investments for AI drug discovery research
    • Market Challenges
      • Concerns regarding data privacy and security
  • Market Segmentation Analysis
    • Offerings: Growing AI-based software adoption owing to its improved functionality & features
    • Technology: Increasing utilization of machine learning technology in the pharmaceutical sector
    • Applications: Improving the efficiency of clinical trial process through AI solutions
    • End-users: Significant implementation of AI technologies by pharma & biotech companies for drug discovery & development
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Artificial Intelligence in Pharmaceutical Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Artificial Intelligence in Pharmaceutical Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery

Merck entered into two new strategic collaborations in the field of drug discovery. These collaborations, with BenevolentAI and Exscientia, aim to utilize Artificial Intelligence (AI)-driven design and discovery capabilities to generate innovative drug candidates for clinical development in areas including oncology, neurology, and immunology. [Published On: 2023-09-20]

Launch of Insilico's Phase II Program Highlights Generative AI Momentum

Insilico Medicine has recently initiated Phase II clinical trials for a groundbreaking drug, INS018_055, developed using generative artificial intelligence in pharmaceuticals. This drug has received Orphan Drug certificate from the FDA and aims to treat idiopathic pulmonary fibrosis (IPF). The utilization of artificial intelligence has significantly accelerated the drug development process for Insilico. Insilico has formed partnerships with several biopharma companies for AI-based drug development projects. [Published On: 2023-08-14]

Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine

Google Cloud introduced two AI-powered solutions for the life sciences industry. These solutions aim to enhance drug discovery and precision medicine for biotechnology companies, pharmaceutical firms, and public sector organizations. The first solution called the Target and Lead Identification Suite, helps researchers gain a better understanding of amino acids' function and predict protein structure. The second solution, known as the Multiomics Suite, expedites the discovery and interpretation of genomic data. [Published On: 2023-05-16]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Artificial Intelligence in Pharmaceutical Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Artificial Intelligence in Pharmaceutical Market, highlighting leading vendors and their innovative profiles. These include AiCure, LLC, Aspen Technology Inc, Atomwise Inc, BenevolentAI SA, BioSymetrics Inc., BPGbio Inc., Butterfly Network, Inc., Cloud Pharmaceuticals, Inc., CloudMedX Inc., Cyclica Inc, Deargen Inc, Deep Genomics Incorporated, Euretos Services BV, Exscientia plc, Google LLC, Insilico Medicine, Intel Corporation, International Business Machines Corporation, InveniAI LLC, Isomorphic Labs, Microsoft Corporation, Novo Nordisk A/S, Oracle Corporation, Sanofi SA, Turbine Ltd., Viseven Europe OU, and XtalPi Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Intelligence in Pharmaceutical Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering
    • Hardware
      • Memory
      • Network
      • Processor
    • Services
      • Deployment & Integration
      • Support & Maintenance
    • Software
  • Technology
    • Computer Vision
    • Context-Aware Computing
    • Machine Learning
    • Natural Language Processing
    • Querying Method
  • Applications
    • Clinical Trials
    • Diagnostic Assistance & Personalized Treatment
    • Drug Development & Discovery
    • Manufacturing
    • Marketing
  • End-users
    • Pharma & Biotech Companies
    • Research Institutes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for personalized medicine to improve treatment outcomes
      • 5.1.1.2. Utilization of AI-driven approaches to enhance existing drug repurposing strategies
      • 5.1.1.3. Need to enhance processing of biomedical and clinical data
    • 5.1.2. Restraints
      • 5.1.2.1. High initial investment for developing and implementing AI solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of innovative AI-based solutions for pharmaceutical industry
      • 5.1.3.2. Significant investments for AI drug discovery research
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns regarding data privacy and security
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offerings: Growing AI-based software adoption owing to its improved functionality & features
    • 5.2.2. Technology: Increasing utilization of machine learning technology in the pharmaceutical sector
    • 5.2.3. Applications: Improving the efficiency of clinical trial process through AI solutions
    • 5.2.4. End-users: Significant implementation of AI technologies by pharma & biotech companies for drug discovery & development
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Artificial Intelligence in Pharmaceutical Market, by Offering

  • 6.1. Introduction
  • 6.2. Hardware
  • 6.3. Services
  • 6.4. Software

7. Artificial Intelligence in Pharmaceutical Market, by Technology

  • 7.1. Introduction
  • 7.2. Computer Vision
  • 7.3. Context-Aware Computing
  • 7.4. Machine Learning
  • 7.5. Natural Language Processing
  • 7.6. Querying Method

8. Artificial Intelligence in Pharmaceutical Market, by Applications

  • 8.1. Introduction
  • 8.2. Clinical Trials
  • 8.3. Diagnostic Assistance & Personalized Treatment
  • 8.4. Drug Development & Discovery
  • 8.5. Manufacturing
  • 8.6. Marketing

9. Artificial Intelligence in Pharmaceutical Market, by End-users

  • 9.1. Introduction
  • 9.2. Pharma & Biotech Companies
  • 9.3. Research Institutes

10. Americas Artificial Intelligence in Pharmaceutical Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Artificial Intelligence in Pharmaceutical Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Artificial Intelligence in Pharmaceutical Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
    • 13.3.2. Launch of Insilico's Phase II Program Highlights Generative AI Momentum
    • 13.3.3. Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET DYNAMICS
  • FIGURE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEMORY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MEMORY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NETWORK, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NETWORK, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROCESSOR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PROCESSOR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT & INTEGRATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DEPLOYMENT & INTEGRATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPORT & MAINTENANCE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SUPPORT & MAINTENANCE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COMPUTER VISION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CONTEXT-AWARE COMPUTING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MACHINE LEARNING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY NATURAL LANGUAGE PROCESSING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY QUERYING METHOD, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC ASSISTANCE & PERSONALIZED TREATMENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DIAGNOSTIC ASSISTANCE & PERSONALIZED TREATMENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY DRUG DEVELOPMENT & DISCOVERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MARKETING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY MARKETING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 73. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 74. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 75. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 76. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 85. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 86. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 87. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 88. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 97. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 98. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 99. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 100. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 109. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 110. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 111. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 112. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 121. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 122. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 123. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 124. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 150. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 151. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 152. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 161. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 162. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 163. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 164. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 173. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 174. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 175. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 176. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 185. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 186. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 187. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 188. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 197. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 198. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 199. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 200. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 209. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 210. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 211. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 212. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 221. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 222. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 223. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 224. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 233. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 234. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 235. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 236. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 245. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 246. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 257. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 258. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 259. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 260. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 269. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 270. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 271. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 272. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY APPLICATIONS, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY END-USERS, 2024-2030 (USD MILLION)
  • TABLE 281. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2018-2023 (USD MILLION)
  • TABLE 282. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY OFFERING, 2024-2030 (USD MILLION)
  • TABLE 283. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2018-2023 (USD MILLION)
  • TABLE 284. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY HARDWARE, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM ARTIFICIAL INTELLIGENCE IN PHARMACEUTICAL MARKET SIZE, BY SE